Igor Puzanov

21PUBLICATIONS
128CO-AUTHORS
Immunogenetics (incl. genetic immunology)Molecular targetsTumour immunologyEvolutionary computationChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Mar 03, 2026
Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data.

Tessa F Flores, Emily S Tonorezos, Shailender Bhatia

|Nov 13, 2025
Multicellular immune ecotypes within solid tumors predict real-world therapeutic benefits with immune checkpoint inhibitors.

Xuefeng Wang, Tingyi Li, Islam Eljilany

|Oct 28, 2025
Genetic haplotypes in VWA8, OSBPL6, and ADAMTS9-AS2 are associated with immune-related adverse effects in ICI-treated patients with cancer.

Prithvi Raj, Jialiang Liu, Chengsong Zhu

|Jun 05, 2025
Inherited mitochondrial genetics as a predictor of immune checkpoint inhibition efficacy in melanoma.

Kelsey R Monson, Robert Ferguson, Joanna E Handzlik

|Dec 17, 2024
Differential Infiltration of Key Immune T-Cell Populations Across Malignancies Varying by Immunogenic Potential and the Likelihood of Response to Immunotherapy.

Islam Eljilany, Sam Coleman, Aik Choon Tan

|Aug 22, 2024
Under-Representation and Under-Reporting of Minoritized Racial and Ethnic Groups in Clinical Trials on Immune Checkpoint Inhibitors.

Alfredo V Chua, Jennifer Delmerico, Haiyang Sheng

Pageof 4

Frequent Collaborators

5 joint publications

Marc S Ernstoff

3 joint publications

Martin McCarter

3 joint publications

John Haanen

3 joint publications

Benjamin Switzer